An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Lubell, Yoel ^a   Hopkins, Heidi ^b,c   Whitty, Christopher J M ^a   Staedke, Sarah G ^a   Mills, Anne ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Uganda Malaria Surveillance Project   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; HISTIDINE RICH PROTEIN 2; LACTATE DEHYDROGENASE; PROTEIN; UNCLASSIFIED DRUG; ARTEMETHER; ARTEMISININ DERIVATIVE; BENFLUMETOL; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; HRP 2 ANTIGEN, PLASMODIUM FALCIPARUM; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ARTICLE; COMPARATIVE STUDY; COST; COST BENEFIT ANALYSIS; DECISION TREE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; ECONOMIC ASPECT; FATALITY; GROUPS BY AGE; HEALTH CARE POLICY; MALARIA; MODEL; OUTCOME ASSESSMENT; PHYSICIAN; PLASMODIUM; PROBABILITY; SENSITIVITY AND SPECIFICITY; UGANDA; ADOLESCENT; ADULT; ANIMAL; CHILD; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; ECONOMICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MULTICENTER STUDY; PRESCHOOL CHILD; URBAN POPULATION;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, PROTOZOAN; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DECISION SUPPORT TECHNIQUES; DECISION TREES; DIAGNOSTIC TESTS, ROUTINE; ETHANOLAMINES; FLUORENES; HUMANS; L-LACTATE DEHYDROGENASE; MALARIA; PLASMODIUM; PROTOZOAN PROTEINS; SENSITIVITY AND SPECIFICITY; UGANDA; URBAN POPULATION;

EID: 40749152765     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-21     Document Type: Article

References (41)

1. Malaria misdiagnosis: effects on the poor and vulnerable. M Amexo R Tolhurst G Barnish I Bates, Lancet 2004 364 1896 1898 10.1016/S0140-6736(04) 17446-1 15555670
2. Trends in antimalarial drug deployment in sub-Saharan Africa. PB Bloland SP Kachur HA Williams, J Exp Biol 2003 206 Pt 21 3761 3769 10.1242/jeb.00637 14506211
3. The detection and treatment of Plasmodium falciparum malaria: Time for change. F Nosten E Ashley, J Postgrad Med 2004 50 1 35 39 15047997
4. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. H Reyburn H Mbakilwa R Mwangi O Mwerinde R Olomi C Drakeley CJ Whitty, Bmj 2007 334 7590 403 17259188 10.1136/bmj.39073.496829.AE
5. Improved diagnostic testing and malaria treatment practices in Zambia. DH Hamer M Ndhlovu D Zurovac M Fox K Yeboah-Antwi P Chanda N Sipilinyambe JL Simon RW Snow, Jama 2007 297 20 2227 2231 10.1001/jama.297.20.2227 17519412
6. Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal. P Agnamey P Brasseur M Cisse O Gaye J Dumoulin J Rigal WR Taylor P Olliaro, Trop Med Int Health 2005 10 9 926 933 10.1111/j.1365-3156.2005.01482.x 16135201
7. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. KI Barnes DN Durrheim F Little A Jackson U Mehta E Allen SS Dlamini J Tsoka B Bredenkamp DJ Mthembu, PLoS Med 2005 2 11 e330 16187798 10.1371/journal.pmed.0020330
8. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study. D Zurovac M Ndhlovu N Sipilanyambe P Chanda DH Hamer JL Simon RW Snow, Malar J 2007 6 31 17367518 10.1186/1475-2875-6-31
9. From chloroquine to artemisinin-based combination therapy: the Sudanese experience. EM Malik TA Mohamed KA Elmardi RM Mowien AH Elhassan SB Elamin AA Mannan ES Ahmed, Malar J 2006 5 65 16879742 10.1186/1475-2875-5-65
10. The cost-effectiveness of parasitological diagnosis for malaria-suspected patients in an era of combination therapy. Y Lubell H Reyburn H Mbakilwa R Mwangi S Chonya CJ Whitty A Mills, Am J Trop Med Hyg 2007 77 6 128 132 18165484
11. Reducing the burden of childhood malaria in Africa: the role of improved diagnostics. ME Rafael T Taylor A Magill YW Lim F Girosi R Allan, Nature 2006 444 Suppl 1 39 48 10.1038/nature05445 17159893
12. Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. SD Shillcutt CM Morel C Goodman GC Coleman D Bell CJ Whitty AJ Mills, Bull World Health Organ 2007
13. The Cost-Effectiveness of Malaria Control Interventions. J Mulligan C Morel A Mills, DCP2 Working paper PROJECT DCP 2005
14. Use of clinical algorithms for diagnosing malaria. D Chandramohan S Jaffar B Greenwood, Trop Med Int Health 2002 7 1 45 52 10.1046/j.1365-3156.2002. 00827.x 11851954
15. Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda. R Ndyomugyenyi P Magnussen S Clarke, Malar J 2007 6 39 17407555 10.1186/1475-2875-6-39
16. Presumptive diagnosis of malaria results in a significant risk of mistreatment of children in urban Sahel. M Olivar M Develoux A Chegou Abari L Loutan, Trans R Soc Trop Med Hyg 1991 85 6 729 730 10.1016/0035-9203(91)90432-X 1801337
17. Determining the Priority Global Health Needs and Quantifying the Health Benefits Resulting From the Introduction of New Diagnostics in the Developing World. F Girosi ME Rafael JE Aledorat YW Lim R Boer K Ricci M Shea EB Keeler, RAND Health RAND 2006
18. Malaria rapid diagnostic tests: one size may not fit all. D Bell, Clin Microbiol Rev 2002 15 4 771 discussion 771-772. 12364379 10.1128/CMR.15.4.771- 772.2002
19. Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. M Mayxay S Pukrittayakamee K Chotivanich S Looareesuwan NJ White, Trans R Soc Trop Med Hyg 2001 95 2 179 182 10.1016/S0035-9203(01)90156-7 11355555
20. Usefulness of an inexpensive, Paracheck test in detecting asymptomatic infectious reservoir of Plasmodium falciparum during dry season in an inaccessible terrain in Central India. N Singh A Saxena VP Sharma, J Infect 2002 45 3 165 168 10.1016/S0163-4453(02)91055-8 12387772
21. Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia. E Tjitra S Suprianto ME Dyer BJ Currie NM Anstey, Am J Trop Med Hyg 2001 65 5 593 598 11716120
22. Performance of the OptiMAL malaria antigen capture dipstick for malaria diagnosis and treatment monitoring at the Hospital for Tropical Diseases, London. A Moody A Hunt-Cooke E Gabbett P Chiodini, Br J Haematol 2000 109 4 891 894 10.1046/j.1365-2141.2000.01974.x 10929047
23. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). R Piper J Lebras L Wentworth A Hunt-Cooke S Houze P Chiodini M Makler, Am J Trop Med Hyg 1999 60 1 109 118 9988333
24. Paracheck-Pf accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis? TD Swarthout H Counihan RK Senga I van den Broek, Malar J 2007 6 58 17506881 10.1186/1475-2875-6-58
25. The burden of malaria: understanding the balance between immunity, public health and control. RW Snow, J Med Microbiol 2000 49 12 1053 1055 11129715
26. Microscopy and outpatient malaria case management among older children and adults in Kenya. D Zurovac B Midia SA Ochola M English RW Snow, Trop Med Int Health 2006 11 4 432 440 10.1111/j.1365-3156.2006.01587.x 16553926
27. Assessing RDT Cost-Effectiveness. S Shillcutt C Morel C Goodman P Coleman C Bombardo CJ Whitty A Mills G Bretas D Bell, WHO 2007
28. The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. Y Lubell H Reyburn H Mbakilwa R Mwangi S Chonya CJ Whitty A Mills, Bmj 2008 336 202 205 18199700 10.1136/bmj.39395.696065.47
29. WHO CHOICE - CHoosing Interventions that are Cost Effective. http://www.who.int/choice/en
30. Perspective Paper 2.1. DB Evans (ed), Cambridge: Cambridge University Press 2004
31. Macroeconomics and health: Investing in health for economic development. J Sachs, Geneva: World Health Organization 2002
32. Malaria transmission and morbidity. K Marsh RW Snow, Parassitologia 1999 41 1-3 241 246 10697862
33. Rapid Diagnostic Tests for Malaria at Sites of Varied Transmission Intensity in Uganda. H Hopkins L Bebell W Kambale C Dokomajilar PJ Rosenthal G Dorsey, JID
34. Essential Malariology. LJ Bruce-Chwatt, Hodder Arnold 4 2002
35. GNI per capita 2005, Atlas method and PPP. World Bank, World Bank 2007
36. Methods for the Economic Evaluation of Health Care Programmes. MF Drummond B O'Brien GL Stoddart GW Torrance MJ Sculpher, Oxford University Press Third 2005
37. On the (near) equivalence of cost-effectiveness and cost-benefit analyses. CE Phelps AI Mushlin, Int J Technol Assess Health Care 1991 7 12 1903360
38. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. A Gafni S Birch, Soc Sci Med 2006 62 9 2091 2100 10.1016/j.socscimed.2005.10. 023 16325975
39. Communicable Diseases. A Mills SD Shillcutt (eds), Cambridge: Cambridge University Press 2004
40. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya. C Goodman W Mutemi E Baya A Willetts V Marsh, Health Policy Plan 2006 21 4 275 288 10.1093/heapol/czl011 16682433
41. The epidemiology of malaria and its measurement. L Molineaux DA Muir HC Spencer WH Wernsdorfer, Malaria, principles and practice of Malariology Edinburgh: Churchill Livingstone 1988 999 1090